LiveBajaj Finance Q1 standalone net profit rises 83% YoY
Bajaj Finance has posted a 83% increase in its standalone net profit for the quarter ended June 30,2018 to Rs.833.7 crore. The company in the same period last...
Category : Latest News
DB Corp Q1 net profit declines 11% to Rs.97 crore
DB Corp has posted 11.39% fall in consolidated net profit to Rs.97.56 crore for the quarter ended June 30,2018. The company in the corresponding quarter...
Cadila gets USFDA approval to market 4 generic products
Zydus Cadila has received final approvals from the US health regulator, to market four generic products in America. The approvals received are for Olanzapine tablets in strengths...
UltraTech Cement Q1 profit slumps 33%
UltraTech Cement profit for the quarter ended June 30,2018, fell 32.9% YoY to Rs.598.39 crore. Revenue from operations rose by 30.6% to Rs.8,655 crore, while in...
Bandhan Bank Q1 net profit increases 47.5% to Rs.481.7 crore
Bandhan Bank has reported a 47.5% increase in its net profit for the quarter ended 30 June,2018. The bank’s profit after tax has been reported at Rs.481.71 crore...
TCNS Clothing IPO opens for subscription today
TCNS Clothing initial public offer (IPO) has opened for subscription today on July 18,2018 and will close on July 20,2018. The company has fixed price band...
HDFC Bank raised Rs.8,500 crore from HDFC Ltd
HDFC Bank has raised Rs.8,500 crore from it parent HDFC Ltd, by issuing over 3.9 crore shares on preferential basis. The bank in a regulatory filing...
REC to consider fund raining up to Rs.70,000 crore through NCDs
Rural Electrification Corporation’s (REC) board will consider a proposal to raise up to Rs.70,000 crore, through issuance of non-convertible debentures on private placement basis. As per...
Sebi gives approval to 3 companies to float IPO
Sebi has given approval to IRCON, PN Gadgil & Sons and KPR Agrochem to float initial public offerings (IPO). Rail PSU IRCON and KPR Agrochem had filed...
Glenmark Pharma receives USFDA nod for Colesevelam Hydrochloride
Glenmark Pharma has received final approval for Colesevelam Hydrochloride, from USFDA. Colesevelam Hydrochloride is a generic version of Welchol 1 of Daiichi Sankyo Inc and the...